What is the Origin of Recombinant FSH Injections?

The term combines "recombinant," referring to the genetic engineering process used for production, "FSH," the abbreviation for Follicle-Stimulating Hormone, and "injections," the route of delivery. It is a cornerstone technology in reproductive endocrinology, replacing older, less pure preparations derived from human urine. This innovation provides a consistent, high-quality therapeutic agent.

What is the Mechanism of Recombinant FSH Injections?

Recombinant FSH injections function by directly binding to and activating the FSH receptors expressed on the granulosa cells of the ovarian follicles in women and on the Sertoli cells of the testes in men. In the female, this activation drives follicular growth, maturation, and subsequent estrogen production. In the male, it provides the necessary signal to support the complex process of sperm production. The high purity ensures maximal receptor specificity and predictable biological response.

Recombinant FSH Injections ∞ Area

Recombinant FSH Injections

Meaning

Recombinant FSH Injections are a pharmaceutical preparation of Follicle-Stimulating Hormone (FSH) manufactured using advanced recombinant DNA technology, administered via a subcutaneous or intramuscular route. This highly purified and standardized hormone is clinically employed to directly stimulate the development of ovarian follicles in women undergoing fertility treatments or to induce spermatogenesis in men with specific forms of hypogonadism. Its use allows for precise control over gonadotropin signaling in reproductive medicine.